microRNAs deregulation in head and neck squamous cell carcinoma

Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic and epigenetic alterations play an important role in HNSCC occurrence and progression. microRNAs (miRNAs) are small noncoding RNAs that regulate cell cy...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck Vol. 43; no. 2; pp. 645 - 667
Main Authors: Carron, Juliana, Torricelli, Caroline, Silva, Janet K., Queiroz, Gabriela S. R., Ortega, Manoela M., Lima, Carmen S. P., Lourenço, Gustavo J.
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-02-2021
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic and epigenetic alterations play an important role in HNSCC occurrence and progression. microRNAs (miRNAs) are small noncoding RNAs that regulate cell cycle, proliferation, development, differentiation, and apoptosis by interfering in gene expression. Expression profiling of miRNAs showed that some miRNAs are upregulated or downregulated in tumor cells when compared with the normal cells. The present review focuses on the role of miRNAs deregulations in HNSCC, enrolled in risk, development, outcome, and therapy sensitivity. Moreover, the influence of single nucleotide variants in miRNAs target sites, miRNAs seed sites, and miRNAs‐processing genes in HNSCC was also revised. Due to its potential for cancer diagnosis, progression, and as a therapeutic target, miRNAs may bring new perspectives in HNSCC understanding and therapy, especially for those patients with no or insufficient treatment options.
AbstractList Abstract Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic and epigenetic alterations play an important role in HNSCC occurrence and progression. microRNAs (miRNAs) are small noncoding RNAs that regulate cell cycle, proliferation, development, differentiation, and apoptosis by interfering in gene expression. Expression profiling of miRNAs showed that some miRNAs are upregulated or downregulated in tumor cells when compared with the normal cells. The present review focuses on the role of miRNAs deregulations in HNSCC, enrolled in risk, development, outcome, and therapy sensitivity. Moreover, the influence of single nucleotide variants in miRNAs target sites, miRNAs seed sites, and miRNAs‐processing genes in HNSCC was also revised. Due to its potential for cancer diagnosis, progression, and as a therapeutic target, miRNAs may bring new perspectives in HNSCC understanding and therapy, especially for those patients with no or insufficient treatment options.
Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic and epigenetic alterations play an important role in HNSCC occurrence and progression. microRNAs (miRNAs) are small noncoding RNAs that regulate cell cycle, proliferation, development, differentiation, and apoptosis by interfering in gene expression. Expression profiling of miRNAs showed that some miRNAs are upregulated or downregulated in tumor cells when compared with the normal cells. The present review focuses on the role of miRNAs deregulations in HNSCC, enrolled in risk, development, outcome, and therapy sensitivity. Moreover, the influence of single nucleotide variants in miRNAs target sites, miRNAs seed sites, and miRNAs‐processing genes in HNSCC was also revised. Due to its potential for cancer diagnosis, progression, and as a therapeutic target, miRNAs may bring new perspectives in HNSCC understanding and therapy, especially for those patients with no or insufficient treatment options.
Author Silva, Janet K.
Torricelli, Caroline
Lima, Carmen S. P.
Carron, Juliana
Lourenço, Gustavo J.
Ortega, Manoela M.
Queiroz, Gabriela S. R.
Author_xml – sequence: 1
  givenname: Juliana
  orcidid: 0000-0002-1108-6343
  surname: Carron
  fullname: Carron, Juliana
  organization: University of Campinas
– sequence: 2
  givenname: Caroline
  surname: Torricelli
  fullname: Torricelli, Caroline
  organization: University of Campinas
– sequence: 3
  givenname: Janet K.
  surname: Silva
  fullname: Silva, Janet K.
  organization: University of Campinas
– sequence: 4
  givenname: Gabriela S. R.
  surname: Queiroz
  fullname: Queiroz, Gabriela S. R.
  organization: University of Campinas
– sequence: 5
  givenname: Manoela M.
  surname: Ortega
  fullname: Ortega, Manoela M.
  organization: São Francisco University
– sequence: 6
  givenname: Carmen S. P.
  orcidid: 0000-0002-1314-2345
  surname: Lima
  fullname: Lima, Carmen S. P.
  organization: University of Campinas
– sequence: 7
  givenname: Gustavo J.
  orcidid: 0000-0002-5944-0305
  surname: Lourenço
  fullname: Lourenço, Gustavo J.
  email: guslour@unicamp.br
  organization: University of Campinas
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33159410$$D View this record in MEDLINE/PubMed
BookMark eNp10M1LwzAYBvAgE_ehB_8BKXjRQ7c3H02Wk4w5nTAUZPeStm9dZ5tujUX235u57SJ4Sgg_Hp48fdKxtUVCrikMKQAbrTAbMhlxfkZ6FLQKgQvV2d8FDzko0SV959YAwKVgF6TLOY20oNAjD1WRNvX768QFGTb40Zbmq6htUNhghSYLjM0Ci-ln4LatqerWBSmWZZCaJi1sXZlLcp6b0uHV8RyQ5dNsOZ2Hi7fnl-lkEaaCah4qpHnGjNSRhkRKASanQqPOGUaQ5xSlMhBJShOWJGiinDPFJB1jahRw4ANyd4jdNPW2RfcVV4XbNzEWfamYiWismBhz4entH7qu28b6cl4pKbQGrr26Pyj_e-cazONNU1Sm2cUU4v2osR81_h3V25tjYptU_vUkTyt6MDqA76LE3f9J8Xz2eIj8AQTmgAE
CitedBy_id crossref_primary_10_1089_dna_2023_0043
crossref_primary_10_1016_j_prp_2023_154510
crossref_primary_10_1186_s12903_022_02425_6
crossref_primary_10_3390_ijms23073808
crossref_primary_10_3390_ijms24054756
crossref_primary_10_1016_j_prp_2023_154954
crossref_primary_10_1016_j_biopha_2023_114512
crossref_primary_10_3390_biomedicines9121894
crossref_primary_10_1177_01455613231158803
crossref_primary_10_1080_00016489_2022_2086292
crossref_primary_10_3390_biomedicines11092407
crossref_primary_10_3892_ol_2023_13958
Cites_doi 10.1016/j.cell.2009.01.002
10.1158/0008-5472.CAN-15-1664
10.1007/s10555-017-9690-0
10.1002/jso.23724
10.1166/jbn.2016.2172
10.1080/15384101.2018.1526601
10.3892/ol.2015.3238
10.1016/j.oooo.2017.05.515
10.1089/dna.2016.3464
10.1186/s13046-019-1283-z
10.1002/jcp.26833
10.1038/mt.2014.5
10.18632/oncotarget.8512
10.1139/bcb-2018-0351
10.7314/APJCP.2015.16.17.7619
10.1371/journal.pone.0046367
10.1038/gt.2011.79
10.1038/s41598-018-25498-2
10.1038/nrm3313
10.1158/0008-5472.CAN-13-0395
10.1111/coa.12785
10.1371/journal.pbio.0020098
10.1074/jbc.M115.700021
10.3892/or.2016.4713
10.3390/ijms20194799
10.1096/fj.12-223420
10.3892/ijmm.2014.1625
10.1001/jamaoncol.2016.4510
10.5114/pjp.2016.63781
10.1371/journal.pone.0037601
10.1186/s13046-019-1119-x
10.1016/j.ebiom.2019.11.016
10.1042/BSR20180273
10.3389/fonc.2019.01305
10.1371/journal.pone.0056395
10.1186/s12885-015-1888-3
10.1158/0008-5472.CAN-10-2754
10.1016/j.bbrc.2016.02.105
10.1002/hed.23011
10.3390/cells8121535
10.1016/j.biopha.2016.11.055
10.12659/MSM.895306
10.1016/j.molcel.2011.07.024
10.1111/jop.12300
10.1155/2012/154303
10.1093/carcin/bgq177
10.1007/s13277-014-1790-7
10.1016/j.canep.2014.07.008
10.1073/pnas.0802682105
10.1007/s10616-012-9430-9
10.1038/cddis.2016.64
10.7314/APJCP.2015.16.17.7589
10.4161/cc.7.6.5834
10.1002/ijc.31638
10.1002/hed.21540
10.1007/s00432-015-2087-y
10.1093/carcin/bgp099
10.1016/S1470-2045(17)30621-6
10.3892/ijmm_00000378
10.1007/s00405-015-3893-1
10.1371/journal.pone.0079584
10.1093/carcin/bgt354
10.1186/1476-4598-13-218
10.18632/oncotarget.13599
10.1007/s13277-015-4682-6
10.1158/1078-0432.CCR-13-2675
10.3322/caac.21492
10.1186/1758-3284-2-15
10.1111/odi.12241
10.1155/2015/298378
10.1016/j.oraloncology.2013.01.001
10.2353/ajpath.2009.080731
10.1371/journal.pone.0102403
10.1016/j.jbiosc.2015.02.002
10.21873/anticanres.12618
10.1007/s00432-013-1469-2
10.1016/j.omtn.2017.06.005
10.1016/j.oooo.2015.02.486
10.1038/bjc.2011.29
10.1002/jcp.29458
10.1177/039463201002300427
10.1016/j.addr.2014.05.009
10.1016/j.oraloncology.2009.12.005
10.1002/hed.26089
10.7150/thno.38507
10.1371/journal.pone.0122851
10.1016/j.neo.2019.06.004
10.1158/0008-5472.CAN-10-1850
10.1158/0008-5472.CAN-10-2010
10.1016/j.addr.2007.03.005
10.1097/CAD.0000000000000865
10.1002/ijc.30849
10.1002/hed.25866
10.1038/sj.bjc.6605811
10.3892/mmr.2016.6059
10.1093/nar/gkm480
10.1371/journal.pone.0047544
10.1038/nm.1880
10.2174/1389201015666140519110616
10.18632/oncotarget.213
10.1002/ijc.23831
10.1016/j.oooo.2013.10.017
10.1007/s13277-014-2406-y
10.1056/NEJMoa1209026
10.2147/OTT.S224325
10.1016/j.gendis.2014.07.002
10.1093/mutage/get035
10.1093/hmg/ddp446
10.1158/1055-9965.EPI-18-0002
10.1093/carcin/bgp277
10.1007/s13277-013-0718-y
10.3389/fonc.2020.00060
10.1038/onc.2013.448
10.1016/S0092-8674(04)00045-5
10.1016/j.febslet.2010.08.040
10.1016/j.canlet.2015.04.006
10.1007/s13277-015-4249-6
10.1038/bjc.2012.330
10.3390/cells8080772
10.3892/or.2011.1571
10.3390/cancers11091347
10.1016/j.biocel.2012.12.004
10.1016/j.canlet.2013.05.032
10.1016/j.rpor.2017.10.003
10.3892/ijo.2014.2704
10.1093/carcin/bgr209
10.1042/BSR20181882
10.1016/j.oraloncology.2017.07.009
10.1158/1078-0432.CCR-07-0666
10.4103/2230-973X.167646
10.1620/tjem.233.33
10.1002/cncr.25009
10.1111/odi.12133
10.1016/j.apsb.2016.09.002
10.1158/0008-5472.CAN-09-2291
10.1111/his.12668
10.1002/jcb.22995
10.1371/journal.pone.0056634
10.1186/s13046-015-0242-6
10.1016/j.biocel.2015.02.006
10.1371/journal.pone.0205077
10.1016/j.bbrc.2012.12.097
10.1158/1078-0432.CCR-08-3053
10.1093/carcin/bgx019
10.18632/aging.101791
10.18632/oncotarget.23194
10.1007/s12032-013-0789-z
10.1186/s40169-018-0211-8
10.1186/1476-4598-13-51
10.1111/j.1600-0714.2010.01005.x
10.4149/neo_2018_180811N611
10.1017/S0022215113000753
10.3892/etm.2016.3847
10.18632/oncotarget.11138
10.1186/s12943-015-0452-8
10.1002/gcc.22099
10.3892/ijmm.2016.2529
10.1111/cas.14259
10.1080/15384047.2014.1001287
10.1186/s13000-015-0256-6
10.12659/MSM.898110
10.1016/j.canlet.2009.05.030
10.1371/journal.pone.0101695
10.1038/s41419-019-2154-4
10.1007/s13277-015-3038-6
10.1111/cas.12499
10.3892/or.2014.2985
10.1016/j.bbrc.2013.02.024
10.1038/nature04303
10.1038/ncb2024
10.1186/s12935-020-1096-3
10.1038/jhg.2015.120
10.1186/s12935-015-0217-x
10.1016/j.molonc.2016.03.001
10.1002/cncr.25323
10.1007/s13353-018-0445-6
10.1016/j.ejca.2015.04.016
10.1074/jbc.M112.366518
10.1093/carcin/bgx056
10.1016/j.biopha.2016.09.047
10.18632/oncotarget.16120
10.5732/cjc.30.0381
10.1111/cpr.12287
10.18632/oncotarget.19224
10.1371/journal.pone.0176044
10.3892/or.2016.4891
10.1002/ijc.25320
10.18632/oncotarget.8908
10.1186/s12920-015-0102-4
10.1002/ijc.23583
10.1038/onc.2009.445
10.3892/mmr.2017.7460
10.1371/journal.pone.0086149
10.1186/s12935-016-0372-8
10.1016/j.oraloncology.2015.08.002
10.1016/j.bbrc.2018.05.052
10.1371/journal.pone.0004029
10.1016/j.ebiom.2016.09.017
10.1245/s10434-012-2618-6
10.1080/21691401.2019.1647222
10.18632/oncotarget.709
10.1186/1476-4598-12-123
10.1016/j.ajhg.2011.03.008
10.1002/cam4.863
10.12659/MSM.895683
10.3892/mmr.2015.4168
10.1158/0008-5472.CAN-13-1297
10.1038/srep07434
10.1016/j.joms.2017.03.025
10.1186/s12964-019-0490-8
10.1158/1078-0432.CCR-18-0716
10.1016/j.redox.2019.101140
10.1155/2014/374598
10.1016/j.lfs.2017.03.010
10.1002/gcc.20765
10.18632/oncotarget.6972
10.1002/cam4.2915
10.18632/oncotarget.9014
10.18632/oncotarget.6253
ContentType Journal Article
Copyright 2020 Wiley Periodicals LLC
2020 Wiley Periodicals LLC.
2021 Wiley Periodicals LLC.
Copyright_xml – notice: 2020 Wiley Periodicals LLC
– notice: 2020 Wiley Periodicals LLC.
– notice: 2021 Wiley Periodicals LLC.
DBID NPM
AAYXX
CITATION
7QP
7TK
K9.
7X8
DOI 10.1002/hed.26533
DatabaseName PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
ProQuest Health & Medical Complete (Alumni)
PubMed

DeliveryMethod fulltext_linktorsrc
EISSN 1097-0347
EndPage 667
ExternalDocumentID 10_1002_hed_26533
33159410
HED26533
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7QP
7TK
K9.
7X8
ID FETCH-LOGICAL-c4193-7e1fd2a69590b6640af149e9f2e50ff1e67a05611b2bbea5f3272618eca70303
IEDL.DBID 33P
ISSN 1043-3074
IngestDate Fri Aug 16 03:04:19 EDT 2024
Thu Oct 10 20:10:40 EDT 2024
Fri Aug 23 05:07:38 EDT 2024
Sat Sep 28 08:46:03 EDT 2024
Sat Aug 24 01:07:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords microRNAs
head and neck cancer
therapy
SNVs
epigenetics
Language English
License 2020 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4193-7e1fd2a69590b6640af149e9f2e50ff1e67a05611b2bbea5f3272618eca70303
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-1108-6343
0000-0002-5944-0305
0000-0002-1314-2345
PMID 33159410
PQID 2476499039
PQPubID 996355
PageCount 23
ParticipantIDs proquest_miscellaneous_2458724834
proquest_journals_2476499039
crossref_primary_10_1002_hed_26533
pubmed_primary_33159410
wiley_primary_10_1002_hed_26533_HED26533
PublicationCentury 2000
PublicationDate February 2021
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: February 2021
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Houston
PublicationTitle Head & neck
PublicationTitleAlternate Head Neck
PublicationYear 2021
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2010; 12
2017; 85
2020; 20
2019; 11
2019; 10
2013; 127
2010; 103
2013; 368
2019; 12
2019; 17
2010; 584
2008; 105
2004; 2
2020; 10
2020; 98
2012; 13
2013; 8
2016; 37
2011; 112
2016; 36
2016; 142
2014; 22
2016; 35
2014; 20
2018; 7
2010; 23
2017; 72
2017; 75
2018; 9
2018; 8
2010; 25
2019; 20
2015; 81
2010; 116
2010; 29
2019; 22
2019; 21
2011; 71
2013; 52
2019; 25
2019; 28
2014; 15
2014; 13
2014; 18
2012; 27
2010; 2
2016; 49
2018; 38
2016; 273
2009; 15
2009; 18
2019; 8
2019; 9
2010; 31
2011; 2
2020; 42
2018; 501
2015; 51
2015; 363
2015; 120
2016; 10
2019; 39
2019; 38
2014; 2014
2009; 174
2008; 123
2018; 23
2012; 107
2016; 12
2016; 5
2015; 67
2016; 7
2018; 17
2010; 49
2010; 46
2020; 31
2019; 41
2015; 61
2013; 73
2018; 233
2013; 337
2019; 47
2014; 38
2015; 2015
2011; 88
2014; 35
2017; 141
2016; 291
2014; 33
2018; 15
2018; 13
2014; 31
2016; 22
2015; 34
2017; 42
2017; 7
2017; 8
2015; 36
2012; 2012
2012; 287
2017; 3
2013; 28
2013; 27
2019; 50
2019; 54
2013; 20
2016; 76
2008; 7
2008; 3
2011; 18
2007; 35
2014; 1
2015; 46
2014; 4
2017; 37
2017; 36
2019; 66
2017; 38
2013; 12
2015; 44
2020; 9
2013; 431
2009; 286
2016; 473
2013; 432
2016; 84
2010; 70
2014; 9
2014; 7
2017; 124
2014; 6
2012; 64
2015; 12
2015; 15
2015; 14
2018; 143
2014; 117
2015; 6
2015; 5
2015; 16
2015; 19
2013; 49
2010; 127
2013; 45
2011; 40
2015; 10
2008; 14
2011; 31
2011; 30
2005; 438
2011; 33
2011; 32
2017; 175
2014; 110
2011; 38
2015; 8
2009; 136
2014; 233
2007; 59
2018; 68
2011; 104
2014; 105
2004; 116
2009; 30
2012; 3
2017; 15
2013; 35
2017; 17
2013; 34
2017; 16
2017; 12
2015; 21
2013; 139
2011; 43
2016; 61
2020; 111
2017; 18
2009; 6
2020; 235
2012; 6
2014; 74
2012; 7
2018; 59
2016; 67
e_1_2_4_217_1
e_1_2_4_172_1
e_1_2_4_232_1
e_1_2_4_80_1
e_1_2_4_42_1
e_1_2_4_65_1
e_1_2_4_27_1
e_1_2_4_88_1
e_1_2_4_100_1
e_1_2_4_123_1
e_1_2_4_146_1
e_1_2_4_169_1
e_1_2_4_161_1
e_1_2_4_184_1
e_1_2_4_228_1
e_1_2_4_205_1
e_1_2_4_220_1
e_1_2_4_9_1
e_1_2_4_92_1
e_1_2_4_31_1
e_1_2_4_77_1
e_1_2_4_54_1
e_1_2_4_16_1
Nohata N (e_1_2_4_191_1) 2011; 38
e_1_2_4_112_1
e_1_2_4_135_1
e_1_2_4_158_1
e_1_2_4_39_1
e_1_2_4_194_1
e_1_2_4_196_1
e_1_2_4_171_1
Arunkumar G (e_1_2_4_212_1) 2018; 15
e_1_2_4_210_1
e_1_2_4_81_1
e_1_2_4_233_1
e_1_2_4_20_1
e_1_2_4_66_1
e_1_2_4_43_1
e_1_2_4_107_1
e_1_2_4_89_1
e_1_2_4_28_1
e_1_2_4_145_1
e_1_2_4_168_1
e_1_2_4_122_1
e_1_2_4_206_1
e_1_2_4_229_1
e_1_2_4_160_1
e_1_2_4_2_1
e_1_2_4_70_1
e_1_2_4_93_1
Hu A (e_1_2_4_127_1) 2014; 6
e_1_2_4_221_1
e_1_2_4_32_1
e_1_2_4_55_1
e_1_2_4_78_1
e_1_2_4_119_1
e_1_2_4_17_1
e_1_2_4_134_1
e_1_2_4_157_1
e_1_2_4_111_1
e_1_2_4_195_1
e_1_2_4_170_1
e_1_2_4_82_1
e_1_2_4_230_1
e_1_2_4_21_1
e_1_2_4_44_1
e_1_2_4_106_1
e_1_2_4_129_1
Ren Y (e_1_2_4_143_1) 2015; 8
e_1_2_4_29_1
e_1_2_4_167_1
e_1_2_4_121_1
e_1_2_4_144_1
e_1_2_4_182_1
e_1_2_4_226_1
e_1_2_4_7_1
e_1_2_4_94_1
e_1_2_4_203_1
e_1_2_4_71_1
e_1_2_4_10_1
e_1_2_4_56_1
e_1_2_4_33_1
e_1_2_4_118_1
e_1_2_4_79_1
e_1_2_4_18_1
e_1_2_4_156_1
e_1_2_4_179_1
e_1_2_4_192_1
e_1_2_4_110_1
e_1_2_4_133_1
Wu TY (e_1_2_4_124_1) 2014; 7
e_1_2_4_83_1
e_1_2_4_231_1
e_1_2_4_60_1
e_1_2_4_45_1
e_1_2_4_22_1
e_1_2_4_105_1
e_1_2_4_128_1
e_1_2_4_68_1
e_1_2_4_189_1
e_1_2_4_120_1
e_1_2_4_166_1
e_1_2_4_204_1
e_1_2_4_227_1
e_1_2_4_181_1
e_1_2_4_95_1
e_1_2_4_8_1
e_1_2_4_72_1
e_1_2_4_11_1
e_1_2_4_34_1
e_1_2_4_117_1
e_1_2_4_57_1
e_1_2_4_19_1
e_1_2_4_178_1
e_1_2_4_155_1
e_1_2_4_193_1
e_1_2_4_132_1
e_1_2_4_199_1
Lu L (e_1_2_4_51_1) 2019; 20
e_1_2_4_84_1
e_1_2_4_213_1
e_1_2_4_236_1
e_1_2_4_61_1
e_1_2_4_23_1
e_1_2_4_46_1
e_1_2_4_69_1
e_1_2_4_104_1
e_1_2_4_142_1
e_1_2_4_165_1
e_1_2_4_188_1
e_1_2_4_180_1
e_1_2_4_5_1
e_1_2_4_209_1
e_1_2_4_96_1
e_1_2_4_73_1
e_1_2_4_224_1
e_1_2_4_50_1
e_1_2_4_201_1
e_1_2_4_12_1
e_1_2_4_116_1
e_1_2_4_139_1
e_1_2_4_35_1
e_1_2_4_58_1
e_1_2_4_190_1
e_1_2_4_131_1
e_1_2_4_154_1
e_1_2_4_177_1
e_1_2_4_85_1
e_1_2_4_62_1
e_1_2_4_214_1
Yan B (e_1_2_4_183_1) 2012; 6
e_1_2_4_24_1
e_1_2_4_149_1
e_1_2_4_126_1
e_1_2_4_103_1
e_1_2_4_141_1
e_1_2_4_187_1
e_1_2_4_164_1
e_1_2_4_6_1
e_1_2_4_74_1
e_1_2_4_202_1
e_1_2_4_225_1
e_1_2_4_13_1
e_1_2_4_36_1
e_1_2_4_59_1
e_1_2_4_97_1
e_1_2_4_138_1
e_1_2_4_115_1
e_1_2_4_130_1
e_1_2_4_176_1
e_1_2_4_153_1
e_1_2_4_151_1
e_1_2_4_197_1
Lou F (e_1_2_4_67_1) 2014; 18
e_1_2_4_219_1
e_1_2_4_40_1
e_1_2_4_63_1
Gallo MEC (e_1_2_4_108_1) 2016; 5
e_1_2_4_211_1
e_1_2_4_234_1
e_1_2_4_25_1
e_1_2_4_48_1
e_1_2_4_86_1
e_1_2_4_125_1
e_1_2_4_148_1
e_1_2_4_102_1
e_1_2_4_163_1
e_1_2_4_186_1
e_1_2_4_140_1
e_1_2_4_3_1
Lim HS (e_1_2_4_30_1) 2017; 37
Zhang T (e_1_2_4_215_1) 2011; 31
Yu WF (e_1_2_4_216_1) 2015; 19
e_1_2_4_52_1
e_1_2_4_90_1
e_1_2_4_222_1
e_1_2_4_75_1
e_1_2_4_14_1
e_1_2_4_98_1
e_1_2_4_114_1
e_1_2_4_137_1
Xu S (e_1_2_4_207_1) 2019; 54
e_1_2_4_152_1
e_1_2_4_175_1
e_1_2_4_150_1
e_1_2_4_173_1
e_1_2_4_198_1
Peng X (e_1_2_4_47_1) 2014; 7
e_1_2_4_41_1
e_1_2_4_235_1
e_1_2_4_109_1
e_1_2_4_64_1
e_1_2_4_49_1
e_1_2_4_87_1
e_1_2_4_26_1
e_1_2_4_147_1
e_1_2_4_101_1
e_1_2_4_185_1
e_1_2_4_162_1
e_1_2_4_208_1
e_1_2_4_4_1
e_1_2_4_91_1
e_1_2_4_200_1
Liu X (e_1_2_4_218_1) 2009; 6
e_1_2_4_223_1
e_1_2_4_53_1
e_1_2_4_76_1
e_1_2_4_15_1
e_1_2_4_38_1
e_1_2_4_99_1
e_1_2_4_113_1
e_1_2_4_159_1
e_1_2_4_136_1
Hu A (e_1_2_4_37_1) 2015; 5
e_1_2_4_174_1
References_xml – volume: 11
  start-page: :1347
  issue: 9
  year: 2019
  end-page: 1369
  article-title: The miR‐205‐5p/BRCA1/RAD17 axis promotes genomic instability in head and neck squamous cell carcinomas
  publication-title: Cancers (Basel)
– volume: 12
  issue: 6
  year: 2017
  article-title: Association between polymorphisms in pre‐miRNA genes and risk of oral squamous cell cancer in a Chinese population
  publication-title: PLoS One
– volume: 5
  start-page: :e336.
  issue: 6
  year: 2016
  article-title: Pharmacokinetics and pharmacodynamics of a 13‐mer LNA‐inhibitor‐miR‐221 in mice and non‐human primates
  publication-title: Mol Ther Nucleic Acids
– volume: 31
  start-page: 260
  issue: 3
  year: 2020
  end-page: 271
  article-title: MicroRNA‐107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro
  publication-title: Anticancer Drugs
– volume: 8
  issue: 11
  year: 2013
  article-title: Association between microRNA polymorphisms and cancer risk based on the findings of 66 case‐control studies
  publication-title: PLoS One
– volume: 51
  start-page: 998
  issue: 11
  year: 2015
  end-page: 1003
  article-title: MicroRNA‐24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma
  publication-title: Oral Oncol
– volume: 20
  start-page: 4340
  issue: 5
  year: 2019
  end-page: 4348
  article-title: A novel seven‐miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients
  publication-title: Mol Med Rep
– volume: 71
  start-page: 2381
  issue: 6
  year: 2011
  end-page: 2391
  article-title: MiR‐218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2‐ROBO1 pathway
  publication-title: Cancer Res
– volume: 31
  start-page: 789
  issue: 1
  year: 2014
  article-title: MiR‐139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells
  publication-title: Med Oncol
– volume: 143
  start-page: 2892
  issue: 11
  year: 2018
  end-page: 2904
  article-title: miR‐134 targets PDCD7 to reduce E‐cadherin expression and enhance oral cancer progression
  publication-title: Int J Cancer
– volume: 29
  start-page: 1580
  year: 2010
  end-page: 1587
  article-title: Regression of murine lung tumors by the let‐7 microRNA
  publication-title: Oncogene
– volume: 142
  start-page: 757
  issue: 4
  year: 2016
  end-page: 766
  article-title: Characterization of miR‐146a and miR‐155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration
  publication-title: J Cancer Res Clin Oncol
– volume: 123
  start-page: 2791
  issue: 12
  year: 2008
  end-page: 2797
  article-title: MicroRNA alterations in head and neck squamous cell carcinoma
  publication-title: Int J Cancer
– volume: 51
  start-page: 1415
  issue: 11
  year: 2015
  end-page: 1423
  article-title: A functional variant at miRNA‐122 binding site in IL‐1α 3' UTR predicts risk and HPV‐positive tumours of oropharyngeal cancer
  publication-title: Eur J Cancer
– volume: 16
  start-page: 7589
  issue: 17
  year: 2015
  end-page: 7594
  article-title: Genetic variation in MicroRNAs and risk of Oral squamous cell carcinoma in south Indian population
  publication-title: Asian Pac J Cancer Prev
– volume: 5
  start-page: 179
  issue: 4
  year: 2015
  end-page: 181
  article-title: An overview of viral and nonviral delivery systems for microRNA
  publication-title: Int J Pharm Investig
– volume: 49
  start-page: 549
  issue: 6
  year: 2010
  end-page: 559
  article-title: Overexpression of dicer as a result of reduced let‐7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells
  publication-title: Genes Chromosomes Cancer
– volume: 35
  start-page: 5953
  issue: 6
  year: 2014
  end-page: 5963
  article-title: MiR‐203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours
  publication-title: Tumour Biol
– volume: 7
  issue: 10
  year: 2012
  article-title: Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case‐control study in Chinese population
  publication-title: PLoS One
– volume: 8
  start-page: 1226
  issue: 1
  year: 2017
  end-page: 1233
  article-title: MiR‐146a rs2910164 polymorphism and head and neck carcinoma risk: a meta‐analysis based on 10 case‐control studies
  publication-title: Oncotarget
– volume: 38
  start-page: 986
  issue: 10
  year: 2017
  end-page: 993
  article-title: Genome‐scale identification of microRNA‐related SNPs associated with risk of head and neck squamous cell carcinoma
  publication-title: Carcinogenesis
– volume: 12
  start-page: 34
  year: 2016
  end-page: 42
  article-title: microRNA therapeutics in Cancer ‐ An emerging concept
  publication-title: EBioMedicine
– volume: 273
  start-page: 4073
  issue: 12
  year: 2016
  end-page: 4080
  article-title: Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer
  publication-title: Eur Arch Otorhinolaryngol
– volume: 20
  start-page: 868
  issue: 4
  year: 2014
  end-page: 877
  article-title: Clusterin is a gene specific target of microRNA‐21 in head and neck squamous cell carcinoma
  publication-title: Clin Cancer Res
– volume: 64
  start-page: 523
  issue: 5
  year: 2012
  end-page: 540
  article-title: A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells
  publication-title: Cytotechnology
– volume: 8
  start-page: 31
  year: 2015
  article-title: Small RNAs in metastatic and non‐metastatic oral squamous cell carcinoma
  publication-title: BMC Med Genomics
– volume: 38
  start-page: 432
  issue: 4
  year: 2017
  end-page: 438
  article-title: Association between miRNA‐binding site polymorphisms in double‐strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non‐oropharynx
  publication-title: Carcinogenesis
– volume: 10
  start-page: 895
  issue: 6
  year: 2016
  end-page: 909
  article-title: IL‐8 induces miR‐424‐5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma
  publication-title: Mol Oncol
– volume: 3
  start-page: 1386
  issue: 11
  year: 2012
  end-page: 1400
  article-title: Tumor suppressive microRNA‐218 inhibits cancer cell migration and invasion through targeting laminin‐332 in head and neck squamous cell carcinoma
  publication-title: Oncotarget
– volume: 6
  start-page: 131
  issue: 3
  year: 2009
  end-page: 139
  article-title: MicroRNA‐222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines
  publication-title: Cancer Genomics Proteomics
– volume: 12
  start-page: 6286
  issue: 4
  year: 2015
  end-page: 6292
  article-title: MicroRNA‐214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells
  publication-title: Mol Med Rep
– volume: 2012
  start-page: 154303
  year: 2012
  article-title: Update of assessment of survival in head and neck cancer after regional recurrence
  publication-title: J Oncol
– volume: 35
  start-page: 4535
  issue: 13
  year: 2007
  end-page: 4541
  article-title: Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers
  publication-title: Nucleic Acids Res
– volume: 15
  start-page: 649
  issue: 1
  year: 2018
  end-page: 657
  article-title: Dysregulation of miR‐200 family microRNAs and epithelial‐mesenchymal transition markers in oral squamous cell carcinoma
  publication-title: Oncol Lett
– volume: 13
  start-page: 51
  year: 2014
  article-title: TGFβR2 is a major target of miR‐93 in nasopharyngeal carcinoma aggressiveness
  publication-title: Mol Cancer
– volume: 32
  start-page: 1668
  issue: 11
  year: 2011
  end-page: 1674
  article-title: A functional variant at the miR‐184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck
  publication-title: Carcinogenesis
– volume: 139
  start-page: 1499
  issue: 9
  year: 2013
  end-page: 1506
  article-title: Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early‐detection markers for laryngeal squamous cell carcinoma
  publication-title: J Cancer Res Clin Oncol
– volume: 107
  start-page: 700
  issue: 4
  year: 2012
  end-page: 706
  article-title: Downregulation of miR‐126 induces angiogenesis and lymphangiogenesis by activation of VEGF‐A in oral cancer
  publication-title: Br J Cancer
– volume: 136
  start-page: 215
  issue: 2
  year: 2009
  end-page: 233
  article-title: MicroRNAs: target recognition and regulatory functions
  publication-title: Cell
– volume: 8
  issue: 2
  year: 2013
  article-title: Prognostic implications of micoRNA miR‐195 expression in human tongue squamous cell carcinoma
  publication-title: PLoS One
– volume: 14
  start-page: 2588
  issue: 9
  year: 2008
  end-page: 2592
  article-title: Mature miR‐184 as potential oncogenic microRNA of squamous cell carcinoma of tongue
  publication-title: Clin Cancer Res
– volume: 49
  start-page: 567
  issue: 6
  year: 2013
  end-page: 575
  article-title: Oncogenic microRNAs as biomarkers of oral tumorigenesis and minimal residual disease
  publication-title: Oral Oncol
– volume: 61
  start-page: 120
  year: 2015
  end-page: 128
  article-title: Identification of miR‐143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling
  publication-title: Int J Biochem Cell Biol
– volume: 127
  start-page: 505
  issue: 3
  year: 2010
  end-page: 512
  article-title: Downregulation of the rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma
  publication-title: Int J Cancer
– volume: 98
  start-page: 83
  issue: 2
  year: 2020
  end-page: 89
  article-title: miR‐140‐5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma
  publication-title: Biochem Cell Biol
– volume: 127
  start-page: S2
  issue: Suppl 2
  year: 2013
  end-page: S7
  article-title: Micro‐ribonucleic acids in head and neck cancer: an introduction
  publication-title: J Laryngol Otol
– volume: 105
  start-page: 7269
  issue: 20
  year: 2008
  end-page: 7274
  article-title: Common SNP in pre‐miR‐146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
  publication-title: Proc Natl Acad Sci USA
– volume: 10
  start-page: 1433
  issue: 3
  year: 2020
  end-page: 1453
  article-title: MicroRNA‐204‐5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma
  publication-title: Theranostics
– volume: 88
  start-page: 458
  issue: 4
  year: 2011
  end-page: 468
  article-title: A genome‐wide comparison of the functional properties of rare and common genetic variants in humans
  publication-title: Am J Hum Genet
– volume: 35
  start-page: 720
  issue: 5
  year: 2013
  end-page: 728
  article-title: Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma
  publication-title: Head Neck
– volume: 42
  start-page: 620
  issue: 3
  year: 2017
  end-page: 628
  article-title: MicroRNA‐203 inhibits tumour growth and metastasis through PDPN
  publication-title: Clin Otolaryngol
– volume: 116
  start-page: 2148
  issue: 9
  year: 2010
  end-page: 2158
  article-title: hsa‐mir‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
  publication-title: Cancer
– volume: 71
  start-page: 225
  issue: 1
  year: 2011
  end-page: 233
  article-title: MiR‐26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2
  publication-title: Cancer Res
– volume: 105
  start-page: 1288
  issue: 10
  year: 2014
  end-page: 1298
  article-title: miR‐639 regulates transforming growth factor beta‐induced epithelial‐mesenchymal transition in human tongue cancer cells by targeting FOXC1
  publication-title: Cancer Sci
– volume: 7
  start-page: 35015
  issue: 23
  year: 2016
  end-page: 35025
  article-title: Significance of microRNA‐related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
  publication-title: Oncotarget
– volume: 12
  start-page: 28
  issue: 1
  year: 2016
  end-page: 42
  article-title: Exploiting nanotechnology for the development of microRNA‐based cancer therapeutics
  publication-title: J Biomed Nanotechnol
– volume: 124
  start-page: 378
  issue: 4
  year: 2017
  end-page: 389.e1
  article-title: The variant of pri‐mir‐26a‐1 polymorphism is associated with decreased risk of betel quid‐related oral premalignant lesions and oral squamous cell carcinoma
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol
– volume: 18
  start-page: 4818
  issue: 24
  year: 2009
  end-page: 4829
  article-title: Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma
  publication-title: Hum Mol Genet
– volume: 4
  start-page: 7434
  year: 2014
  article-title: Genetic variants in let‐7/Lin28 modulate the risk of oral cavity cancer in a Chinese Han population
  publication-title: Sci Rep
– volume: 43
  start-page: 892
  issue: 6
  year: 2011
  end-page: 903
  article-title: Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants
  publication-title: Mol Cell
– volume: 28
  start-page: 577
  issue: 5
  year: 2013
  end-page: 582
  article-title: Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population
  publication-title: Mutagenesis
– volume: 47
  start-page: 3278
  issue: 1
  year: 2019
  end-page: 3285
  article-title: MiR‐638 suppresses the progression of oral squamous cell carcinoma through wnt/β‐catenin pathway by targeting phospholipase D1
  publication-title: Artif Cells Nanomed Biotechnol
– volume: 12
  start-page: 247
  year: 2010
  end-page: 256
  article-title: miR‐9, a MYC/MYCN‐activated microRNA, regulates E‐cadherin and cancer metastasis
  publication-title: Nat Cell Biol
– volume: 2
  start-page: 29
  issue: 1–2
  year: 2011
  end-page: 42
  article-title: miR‐1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
  publication-title: Oncotarget
– volume: 116
  start-page: 281
  issue: 2
  year: 2004
  end-page: 297
  article-title: MicroRNAs: genomics, biogenesis, mechanism, and function
  publication-title: Cell
– volume: 25
  start-page: 565
  issue: 4
  year: 2010
  end-page: 571
  article-title: Hsa‐miR‐34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c‐met
  publication-title: Int J Mol Med
– volume: 17
  start-page: 2284
  issue: 18
  year: 2018
  end-page: 2295
  article-title: Loss of miR‐16 contributes to tumor progression by activation of tousled‐like kinase 1 in oral squamous cell carcinoma
  publication-title: Cell Cycle
– volume: 68
  start-page: 394
  issue: 6
  year: 2018
  end-page: 424
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 11
  start-page: 921
  issue: 3
  year: 2019
  end-page: 932
  article-title: MicroRNA‐141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma
  publication-title: Aging (Albany NY)
– volume: 2015
  start-page: 298378
  year: 2015
  article-title: Association of polymorphic variants of miRNA processing genes with larynx cancer risk in a polish population
  publication-title: Biomed Res Int
– volume: 2
  start-page: 15
  year: 2010
  article-title: Meta‐analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
  publication-title: Head Neck Oncol
– volume: 117
  start-page: 227
  issue: 2
  year: 2014
  end-page: 233
  article-title: Upregulation of a potential prognostic biomarker, miR‐155, enhances cell proliferation in patients with oral squamous cell carcinoma
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol
– volume: 9
  start-page: 3663
  issue: 3
  year: 2018
  end-page: 3676
  article-title: Inhibition of integrin β1‐mediated oncogenic signalling by the antitumor
  publication-title: Oncotarget
– volume: 66
  start-page: 507
  issue: 4
  year: 2019
  end-page: 515
  article-title: MicroRNA‐101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma
  publication-title: Neoplasma
– volume: 9
  start-page: 1305
  year: 2019
  article-title: Expanding the transcriptome of head and neck squamous cell carcinoma through novel microRNA discovery
  publication-title: Front Oncol
– volume: 7
  start-page: 8223
  issue: 7
  year: 2016
  end-page: 8239
  article-title: microRNA‐203 suppresses invasion and epithelial‐mesenchymal transition induction via targeting NUAK1 in head and neck cancer
  publication-title: Oncotarget
– volume: 291
  start-page: 10571
  issue: 20
  year: 2016
  end-page: 10585
  article-title: Up‐regulation of histone methyltransferase, DOT1L, by matrix Hyaluronan promotes MicroRNA‐10 expression leading to tumor cell invasion and chemoresistance in cancer stem cells from head and neck squamous cell carcinoma
  publication-title: J Biol Chem
– volume: 17
  start-page: 2
  year: 2017
  article-title: miR‐324‐3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma
  publication-title: Cancer Cell Int
– volume: 16
  start-page: 261
  issue: 2
  year: 2015
  end-page: 267
  article-title: MiR‐1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo
  publication-title: Cancer Biol Ther
– volume: 25
  start-page: 2860
  issue: 9
  year: 2019
  end-page: 2873
  article-title: Integrated genomic and functional microRNA analysis identifies miR‐30‐5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer
  publication-title: Clin Cancer Res
– volume: 35
  start-page: 3541
  issue: 6
  year: 2016
  end-page: 3547
  article-title: miR‐491‐5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma
  publication-title: Oncol Rep
– volume: 8
  start-page: 4588
  issue: 5
  year: 2015
  end-page: 4594
  article-title: MiRNA‐139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway
  publication-title: Int J Clin Exp Pathol
– volume: 18
  start-page: 1386
  issue: 10
  year: 2017
  end-page: 1396
  article-title: Safety and activity of microRNA‐loaded minicells in patients with recurrent malignant pleural mesothelioma: a first‐in‐man, phase 1, open‐label, dose‐escalation study
  publication-title: Lancet Oncol
– volume: 39
  start-page: :BSR20181882.
  issue: 1
  year: 2019
  article-title: MicroRNA‐625 inhibits cell invasion and epithelial‐mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma
  publication-title: Biosci Rep
– volume: 21
  start-page: 195
  issue: 2
  year: 2015
  end-page: 206
  article-title: The association between miR‐499a polymorphism and oral squamous cell carcinoma progression
  publication-title: Oral Dis
– volume: 20
  start-page: e65
  issue: 3
  year: 2014
  end-page: e75
  article-title: MiR‐99a exerts anti‐metastasis through inhibiting myotubularin‐related protein 3 expression in oral cancer
  publication-title: Oral Dis
– volume: 7
  start-page: 26444
  issue: 18
  year: 2016
  end-page: 26453
  article-title: Pre‐miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx
  publication-title: Oncotarget
– volume: 33
  start-page: 5017
  issue: 42
  year: 2014
  end-page: 5027
  article-title: MicroRNA‐9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β‐catenin signaling pathway
  publication-title: Oncogene
– volume: 120
  start-page: 351
  issue: 4
  year: 2015
  end-page: 358
  article-title: miR‐203 downregulates Yes‐1 and suppresses oncogenic activity in human oral cancer cells
  publication-title: J Biosci Bioeng
– volume: 18
  start-page: 2444
  issue: 17
  year: 2014
  end-page: 2452
  article-title: Two polymorphisms of CD44 3'UTR weaken the binding of miRNAs and associate with naso‐pharyngeal carcinoma in a Chinese population
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 9
  start-page: 2631
  year: 2020
  end-page: 2642
  article-title: Two miRNA prognostic signatures of head and neck squamous cell carcinoma: a bioinformatic analysis based on the TCGA dataset
  publication-title: Cancer Med
– volume: 473
  start-page: 382
  issue: 2
  year: 2016
  end-page: 387
  article-title: miR‐203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer
  publication-title: Biochem Biophys Res Commun
– volume: 76
  start-page: 4872
  issue: 16
  year: 2016
  end-page: 4886
  article-title: MicroRNA‐211 enhances the oncogenicity of carcinogen‐induced oral carcinoma by repressing TCF12 and increasing antioxidant activity
  publication-title: Cancer Res
– volume: 501
  start-page: 584
  issue: 2
  year: 2018
  end-page: 592
  article-title: miR‐196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2
  publication-title: Biochem Biophys Res Commun
– volume: 16
  start-page: 7154
  issue: 5
  year: 2017
  end-page: 7162
  article-title: MicroRNA‐195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1
  publication-title: Mol Med Rep
– volume: 38
  start-page: :BSR20180273.
  issue: 4
  year: 2018
  article-title: A comprehensive evaluation for polymorphisms in let‐7 family in cancer risk and prognosis: a system review and meta‐analysis
  publication-title: Biosci Rep
– volume: 10
  start-page: 22
  year: 2015
  article-title: High microRNA‐23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis
  publication-title: Diagn Pathol
– volume: 286
  start-page: 217
  issue: 2
  year: 2009
  end-page: 222
  article-title: MicroRNA‐138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines
  publication-title: Cancer Lett
– volume: 15
  start-page: 61
  year: 2015
  article-title: MicroRNA‐24 inhibits growth, induces apoptosis, and reverses radioresistance in laryngeal squamous cell carcinoma by targeting X‐linked inhibitor of apoptosis protein
  publication-title: Cancer Cell Int
– volume: 36
  start-page: 3949
  issue: 5
  year: 2015
  end-page: 3956
  article-title: Increased expression of miR‐93 is associated with poor prognosis in head and neck squamous cell carcinoma
  publication-title: Tumour Biol
– volume: 13
  start-page: 239
  issue: 4
  year: 2012
  end-page: 250
  article-title: MicroRNAs in metabolism and metabolic disorders
  publication-title: Nat Rev Mol Cell Biol
– volume: 31
  start-page: 2118
  issue: 12
  year: 2010
  end-page: 2123
  article-title: MicroRNA‐related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early‐stage head and neck cancer
  publication-title: Carcinogenesis
– volume: 31
  start-page: 1255
  issue: 3
  year: 2014
  end-page: 1262
  article-title: miR‐222 regulates the cell biological behavior of oral squamous cell carcinoma by targeting PUMA
  publication-title: Oncol Rep
– volume: 40
  start-page: 560
  issue: 7
  year: 2011
  end-page: 566
  article-title: miR‐221 and miR‐222 expression increased the growth and tumorigenesis of oral carcinoma cells
  publication-title: J Oral Pathol Med
– volume: 36
  start-page: 425
  issue: 3
  year: 2017
  end-page: 434
  article-title: Alcohol and head and neck cancer
  publication-title: Cancer Metastasis Rev
– volume: 9
  issue: 1
  year: 2014
  article-title: Knockdown of miR‐214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma
  publication-title: PLoS One
– volume: 38
  start-page: 209
  issue: 1
  year: 2011
  end-page: 217
  article-title: Caveolin‐1 mediates tumor cell migration and invasion and its regulation by miR‐133a in head and neck squamous cell carcinoma
  publication-title: Int J Oncol
– volume: 22
  start-page: 101140
  year: 2019
  article-title: miR‐125b suppresses oral oncogenicity by targeting the anti‐oxidative gene PRXL2A
  publication-title: Redox Biol
– volume: 1
  start-page: 75
  issue: 1
  year: 2014
  end-page: 86
  article-title: Unraveling the molecular genetics of head and neck cancer through genome‐wide approaches
  publication-title: Genes Dis
– volume: 31
  start-page: 3859
  issue: 11
  year: 2011
  end-page: 3863
  article-title: Down‐regulation of MiR‐206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression
  publication-title: Anticancer Res
– volume: 75
  start-page: 1449.e1
  issue: 7
  year: 2017
  end-page: 1449.e8
  article-title: Loss of PTEN expression is associated with high microRNA 24 level and poor prognosis in patients with tongue squamous cell carcinoma
  publication-title: J Oral Maxillofac Surg
– volume: 74
  start-page: 751
  issue: 3
  year: 2014
  end-page: 764
  article-title: miRNA‐491‐5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis
  publication-title: Cancer Res
– volume: 72
  start-page: 56
  year: 2017
  end-page: 64
  article-title: A comprehensive study of smoking‐specific microRNA alterations in head and neck squamous cell carcinoma
  publication-title: Oral Oncol
– volume: 3
  start-page: 220
  issue: 2
  year: 2017
  end-page: 226
  article-title: Effect of standard radiotherapy with cisplatin vs accelerated radiotherapy with panitumumab in locoregionally advanced squamous cell head and neck carcinoma: a randomized clinical trial
  publication-title: JAMA Oncol
– volume: 233
  start-page: 33
  issue: 1
  year: 2014
  end-page: 41
  article-title: Polymorphisms of microRNA‐binding sites in integrin genes are associated with oral squamous cell carcinoma susceptibility and progression
  publication-title: Tohoku J Exp Med
– volume: 584
  start-page: 4115
  issue: 18
  year: 2010
  end-page: 4120
  article-title: MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinoma
  publication-title: FEBS Lett
– volume: 46
  start-page: 161
  issue: 1
  year: 2015
  end-page: 174
  article-title: MicroRNA‐93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma
  publication-title: Int J Oncol
– volume: 7
  issue: 10
  year: 2012
  article-title: Circulating miR‐17, miR‐20a, miR‐29c, and miR‐223 combined as non‐invasive biomarkers in nasopharyngeal carcinoma
  publication-title: PLoS One
– volume: 22
  start-page: 522
  year: 2016
  end-page: 529
  article-title: Downregulation of microrna‐126 contributes to tumorigenesis of squamous tongue cell carcinoma via targeting KRAS
  publication-title: Med Sci Monit
– volume: 59
  start-page: 301
  issue: 3
  year: 2018
  end-page: 304
  article-title: Single nucleotide polymorphism rs11614913 associated with CC genotype in miR‐196a2 is overrepresented in laryngeal squamous cell carcinoma, but not salivary gland tumors in Polish population
  publication-title: J Appl Genet.
– volume: 46
  start-page: 204
  issue: 3
  year: 2010
  end-page: 208
  article-title: miR‐24 up‐regulation in oral carcinoma: positive association from clinical and in vitro analysis
  publication-title: Oral Oncol
– volume: 38
  start-page: 3477
  issue: 6
  year: 2018
  end-page: 3485
  article-title: MicroRNA‐203 induces apoptosis by targeting
  publication-title: Anticancer Res
– volume: 104
  start-page: 830
  issue: 5
  year: 2011
  end-page: 840
  article-title: Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study
  publication-title: Br J Cancer
– volume: 35
  start-page: 11075
  issue: 11
  year: 2014
  end-page: 11079
  article-title: Expression and clinical significance of microRNA‐152 in supragalottic laryngeal carcinoma
  publication-title: Tumour Biol
– volume: 28
  start-page: 127
  issue: 1
  year: 2019
  end-page: 136
  article-title: MicroRNA‐related genetic variants associated with survival of head and neck squamous cell carcinoma
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 7
  start-page: 33
  year: 2018
  article-title: Combination therapy to checkmate Glioblastoma: clinical challenges and advances
  publication-title: Clin Transl Med
– volume: 30
  start-page: 1003
  issue: 6
  year: 2009
  end-page: 1007
  article-title: A let‐7 microRNA‐binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers
  publication-title: Carcinogenesis
– volume: 67
  start-page: 283
  issue: 3
  year: 2016
  end-page: 290
  article-title: Evaluation of polymorphisms in microRNA biosynthesis genes and risk of laryngeal cancer in the Polish population
  publication-title: Pol J Pathol
– volume: 18
  start-page: 1121
  issue: 12
  year: 2011
  end-page: 1126
  article-title: Developing therapeutic microRNAs for cancer
  publication-title: Gene Ther
– volume: 103
  start-page: 877
  issue: 6
  year: 2010
  end-page: 884
  article-title: miR‐489 is a tumour‐suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)
  publication-title: Br J Cancer
– volume: 41
  start-page: 3499
  issue: 10
  year: 2019
  end-page: 3515
  article-title: MicroRNA expression patterns in oral squamous cell carcinoma: hsa‐mir‐99b‐3p and hsa‐mir‐100‐5p as novel prognostic markers for oral cancer
  publication-title: Head Neck
– volume: 363
  start-page: 146
  issue: 2
  year: 2015
  end-page: 155
  article-title: MicroRNA‐93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog‐2
  publication-title: Cancer Lett
– volume: 50
  start-page: 135
  year: 2019
  end-page: 143
  article-title: Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC
  publication-title: EBioMedicine
– volume: 15
  start-page: 503
  issue: 5
  year: 2014
  end-page: 508
  article-title: miR‐21, miR‐106b and miR‐375 as novel potential biomarkers for laryngeal squamous cell carcinoma
  publication-title: Curr Pharm Biotechnol
– volume: 174
  start-page: 736
  issue: 3
  year: 2009
  end-page: 745
  article-title: Low‐level expression of microRNAs let‐7d and miR‐205 are prognostic markers of head and neck squamous cell carcinoma
  publication-title: Am J Pathol
– volume: 13
  start-page: 218
  year: 2014
  article-title: OncomiR‐196 promotes an invasive phenotype in oral cancer through the NME4‐JNK‐TIMP1‐MMP signaling pathway
  publication-title: Mol Cancer
– volume: 431
  start-page: 610
  issue: 3
  year: 2013
  end-page: 616
  article-title: miR‐9 modulates the expression of interferon‐regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
  publication-title: Biochem Biophys Res Commun
– volume: 38
  start-page: 281
  issue: 1
  year: 2019
  article-title: MicroRNA‐486‐3p functions as a tumor suppressor in oral cancer by targeting DDR1
  publication-title: J Exp Clin Cancer Res
– volume: 22
  start-page: 289
  year: 2016
  end-page: 294
  article-title: Association of Decreased Expression of serum miR‐9 with poor prognosis of Oral squamous cell carcinoma patients
  publication-title: Med Sci Monit
– volume: 13
  issue: 10
  year: 2018
  article-title: Smoking‐induced control of miR‐133a‐3p alters the expression of EGFR and HuR in HPV‐infected oropharyngeal cancer
  publication-title: PLoS One
– volume: 45
  start-page: 513
  issue: 3
  year: 2013
  end-page: 520
  article-title: Dysregulated miR‐363 affects head and neck cancer invasion and metastasis by targeting podoplanin
  publication-title: Int J Biochem Cell Biol
– volume: 5
  start-page: 3489
  issue: 12
  year: 2016
  end-page: 3499
  article-title: MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21
  publication-title: Cancer Med
– volume: 10
  start-page: 410
  issue: 1
  year: 2015
  end-page: 416
  article-title: Upregulation of microRNA‐23a regulates proliferation and apoptosis by targeting APAF‐1 in laryngeal carcinoma
  publication-title: Oncol Lett
– volume: 368
  start-page: 1685
  issue: 18
  year: 2013
  end-page: 1694
  article-title: Treatment of HCV infection by targeting microRNA
  publication-title: N Engl J Med
– volume: 23
  start-page: 6
  issue: 1
  year: 2018
  end-page: 20
  article-title: Characteristic miRNA expression signature and random forest survival analysis identify potential cancer‐driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes
  publication-title: Rep Pract Oncol Radiother
– volume: 34
  start-page: 1793
  issue: 3
  year: 2013
  end-page: 1800
  article-title: miR‐214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma
  publication-title: Tumour Biol
– volume: 12
  start-page: 10441
  year: 2019
  end-page: 10453
  article-title: miR‐424‐5p promotes proliferation, migration and invasion of laryngeal squamous cell carcinoma
  publication-title: Onco Targets Ther
– volume: 9
  issue: 7
  year: 2014
  article-title: MicroRNAs MiR‐218, MiR‐125b, and let‐7g predict prognosis in patients with oral cavity squamous cell carcinoma
  publication-title: PLoS One
– volume: 36
  start-page: 581
  issue: 7
  year: 2017
  end-page: 588
  article-title: Altered expression of miRNAs is related to larynx cancer TNM stage and patients' smoking status
  publication-title: DNA Cell Biol
– volume: 14
  start-page: 1271
  year: 2008
  end-page: 1277
  article-title: The miR‐15a‐miR‐16‐1 cluster controls prostate cancer by targeting multiple oncogenic activities
  publication-title: Nat Med
– volume: 120
  start-page: 43
  issue: 1
  year: 2015
  end-page: 51
  article-title: Micro‐ribonucleic acid 143 (MiR‐143) inhibits oral squamous cell carcinoma (OSCC) cell migration and invasion by downregulation of phospho‐c‐met through targeting CD44 v3
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol
– volume: 7
  start-page: 56
  issue: 1
  year: 2014
  end-page: 63
  article-title: MiR‐19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP‐2 expression
  publication-title: Int J Clin Exp Pathol
– volume: 12
  start-page: 3749
  issue: 6
  year: 2016
  end-page: 3755
  article-title: Functions of microRNA‐143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma
  publication-title: Exp Ther Med
– volume: 15
  start-page: 948
  issue: 2
  year: 2017
  end-page: 956
  article-title: MicroRNA‐152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma
  publication-title: Mol Med Rep
– volume: 10
  start-page: 916
  issue: 12
  year: 2019
  article-title: Reciprocal regulation of miR‐1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma
  publication-title: Cell Death Dis
– volume: 85
  start-page: 486
  year: 2017
  end-page: 492
  article-title: CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway
  publication-title: Biomed Pharmacother
– volume: 59
  start-page: 75
  issue: 2–3
  year: 2007
  end-page: 86
  article-title: RNAi therapeutics: principles, prospects and challenges
  publication-title: Adv Drug Deliv Rev
– volume: 84
  start-page: 608
  year: 2016
  end-page: 613
  article-title: Enhanced miR‐9 promotes laryngocarcinoma cell survival via down‐regulating PTEN
  publication-title: Biomed Pharmacother
– volume: 112
  start-page: 872
  issue: 3
  year: 2011
  end-page: 880
  article-title: miR‐21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion
  publication-title: J Cell Biochem
– volume: 7
  start-page: 6784
  issue: 10
  year: 2014
  end-page: 6791
  article-title: MiR‐634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo
  publication-title: Int J Clin Exp Pathol
– volume: 49
  start-page: 628
  issue: 5
  year: 2016
  end-page: 635
  article-title: MicroRNA‐137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion
  publication-title: Cell Prolif
– volume: 38
  start-page: 591
  issue: 5
  year: 2014
  end-page: 598
  article-title: A let‐7 microRNA polymorphism in the KRAS 3'‐UTR is prognostic in oropharyngeal cancer
  publication-title: Cancer Epidemiol
– volume: 233
  start-page: 9447
  issue: 12
  year: 2018
  end-page: 9457
  article-title: MicroRNA‐16 functions as a tumor‐suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2
  publication-title: J Cell Physiol
– volume: 8
  issue: 2
  year: 2013
  article-title: Overexpression of miR‐155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3
  publication-title: PLoS One
– volume: 19
  start-page: 2697
  issue: 14
  year: 2015
  end-page: 2702
  article-title: miR‐206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 5
  start-page: 1775
  issue: 5
  year: 2015
  end-page: 1785
  article-title: MiR‐21/miR‐375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma
  publication-title: Am J Cancer Res
– volume: 37
  start-page: 1274
  issue: 5
  year: 2016
  end-page: 1280
  article-title: Overexpression of miR‐155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2
  publication-title: Int J Mol Med
– volume: 21
  start-page: 849
  issue: 9
  year: 2019
  end-page: 862
  article-title: miR‐125a‐5p functions as tumor suppressor microRNA and is a marker of locoregional recurrence and poor prognosis in head and neck cancer
  publication-title: Neoplasia
– volume: 73
  start-page: 5151
  issue: 16
  year: 2013
  end-page: 5162
  article-title: A sequence polymorphism in miR‐608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma
  publication-title: Cancer Res
– volume: 9
  issue: 7
  year: 2014
  article-title: Integrative approach detected association between genetic variants of microRNA binding sites of TLRs pathway genes and OSCC susceptibility in Chinese Han population
  publication-title: PLoS One
– volume: 110
  start-page: 551
  issue: 5
  year: 2014
  end-page: 574
  article-title: Current treatment of head and neck squamous cell cancer
  publication-title: J Surg Oncol
– volume: 37
  start-page: 5425
  issue: 10
  year: 2017
  end-page: 5433
  article-title: Suppression of oral carcinoma oncogenic activity by microRNA‐203
  publication-title: Anticancer Res
– volume: 7
  issue: 5
  year: 2012
  article-title: Dysregulation of microRNA‐34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis
  publication-title: PLoS One
– volume: 10
  start-page: 60
  year: 2020
  article-title: miR‐936 suppresses cell proliferation, invasion, and drug resistance of laryngeal squamous cell carcinoma and targets GPR78
  publication-title: Front Oncol
– volume: 432
  start-page: 660
  issue: 4
  year: 2013
  end-page: 665
  article-title: A miR‐151 binding site polymorphism in the 3′‐untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma
  publication-title: Biochem Biophys Res Commun
– volume: 6
  start-page: 675
  issue: 3
  year: 2012
  end-page: 681
  article-title: Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells
  publication-title: Mol Med Rep
– volume: 6
  start-page: 44538
  issue: 42
  year: 2015
  end-page: 44550
  article-title: Deregulation of the miR‐222‐ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential
  publication-title: Oncotarget
– volume: 235
  start-page: 8035
  year: 2020
  end-page: 8047
  article-title: MiR‐4282 inhibits tumor progression through down‐regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma
  publication-title: J Cell Physiol
– volume: 141
  start-page: 1355
  issue: 7
  year: 2017
  end-page: 1364
  article-title: Genetic variants in microRNA‐binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx
  publication-title: Int J Cancer
– volume: 38
  start-page: 141
  issue: 1
  year: 2019
  article-title: miR‐96‐5p targets PTEN expression affecting radio‐chemosensitivity of HNSCC cells
  publication-title: J Exp Clin Cancer Res
– volume: 52
  start-page: 1042
  issue: 11
  year: 2013
  end-page: 1052
  article-title: Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis
  publication-title: Genes Chromosomes Cancer
– volume: 36
  start-page: 1143
  issue: 2
  year: 2016
  end-page: 1149
  article-title: miR‐24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7
  publication-title: Oncol Rep
– volume: 54
  start-page: 1245
  issue: 4
  year: 2019
  end-page: 1255
  article-title: Upregulation of microRNA‐194‐5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway
  publication-title: Int J Oncol
– volume: 67
  start-page: 491
  issue: 4
  year: 2015
  end-page: 500
  article-title: The prognostic role of the epithelial‐mesenchymal transition markers E‐cadherin and Slug in laryngeal squamous cell carcinoma
  publication-title: Histopathology
– volume: 8
  start-page: 55511
  issue: 33
  year: 2017
  end-page: 55524
  article-title: Meta‐analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms
  publication-title: Oncotarget
– volume: 30
  start-page: 381
  issue: 6
  year: 2011
  end-page: 391
  article-title: Single‐nucleotide polymorphisms among microRNA: big effects on cancer
  publication-title: Chin J Cancer
– volume: 14
  start-page: 181
  year: 2015
  article-title: Alcohol‐dysregulated miR‐30a and miR‐934 in head and neck squamous cell carcinoma
  publication-title: Mol Cancer
– volume: 37
  start-page: 8057
  issue: 6
  year: 2016
  end-page: 8066
  article-title: A variant at a potentially functional microRNA‐binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck
  publication-title: Tumour Biol
– volume: 15
  start-page: 3998
  issue: 12
  year: 2009
  end-page: 4008
  article-title: MiR‐21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor
  publication-title: Clin Cancer Res
– volume: 7
  start-page: 759
  year: 2008
  end-page: 764
  article-title: The let‐7 microRNA reduces tumor growth in mouse models of lung cancer
  publication-title: Cell Cycle
– volume: 30
  start-page: 2059
  issue: 12
  year: 2009
  end-page: 2063
  article-title: MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
  publication-title: Carcinogenesis
– volume: 12
  start-page: 123
  issue: 1
  year: 2013
  article-title: MiR‐451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma
  publication-title: Mol Cancer
– volume: 3
  issue: 12
  year: 2008
  article-title: The inhibition of the highly expressed miR‐221 and miR‐222 impairs the growth of prostate carcinoma xenografts in mice
  publication-title: PLoS One
– volume: 33
  start-page: 879
  issue: 4
  year: 2014
  end-page: 886
  article-title: Role of miR‐200c/miR‐141 in the regulation of epithelial‐mesenchymal transition and migration in head and neck squamous cell carcinoma
  publication-title: Int J Mol Med
– volume: 33
  start-page: 786
  issue: 6
  year: 2011
  end-page: 791
  article-title: MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel‐induced multidrug resistance
  publication-title: Head Neck
– volume: 8
  start-page: 1535
  issue: 12
  year: 2019
  article-title: Regulation of oncogenic targets by miR‐99a‐3p (passenger strand of miR‐99a‐duplex) in head and neck squamous cell carcinoma
  publication-title: Cells.
– volume: 20
  start-page: 14
  year: 2020
  article-title: Silencing of miR‐17‐5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma
  publication-title: Cancer Cell Int
– volume: 287
  start-page: 29261
  issue: 35
  year: 2012
  end-page: 29272
  article-title: Keratinization‐associated miR‐7 and miR‐21 regulate tumor suppressor reversion‐inducing cysteine‐rich protein with kazal motifs (RECK) in oral cancer
  publication-title: J Biol Chem
– volume: 116
  start-page: 4753
  issue: 20
  year: 2010
  end-page: 4760
  article-title: Genetic variants in selected pre‐microRNA genes and the risk of squamous cell carcinoma of the head and neck
  publication-title: Cancer
– volume: 22
  start-page: 1151
  year: 2014
  end-page: 1163
  article-title: Multifunctional aptamer‐miRNA conjugates for targeted cancer therapy
  publication-title: Mol Ther
– volume: 34
  start-page: 130
  year: 2015
  article-title: MiR‐24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1
  publication-title: J Exp Clin Cancer Res
– volume: 7
  start-page: 34472
  issue: 23
  year: 2016
  end-page: 34479
  article-title: A functional variant at miRNA‐122 binding site in IL‐1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer
  publication-title: Oncotarget
– volume: 22
  start-page: 4330
  year: 2016
  end-page: 4337
  article-title: MicroRNA‐152 targets phosphatase and tensin homolog to inhibit apoptosis and promote cell migration of nasopharyngeal carcinoma cells
  publication-title: Med Sci Monit
– volume: 44
  start-page: 792
  issue: 10
  year: 2015
  end-page: 800
  article-title: Altered levels of miR‐21, miR‐125b‐2*, miR‐138, miR‐155, miR‐184, and miR‐205 in oral squamous cell carcinoma and association with clinicopathological characteristics
  publication-title: J Oral Pathol Med
– volume: 27
  start-page: 1097
  issue: 4
  year: 2012
  end-page: 1103
  article-title: miR‐24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down‐regulation of the S100A8 protein
  publication-title: Oncol Rep
– volume: 123
  start-page: 251
  issue: 2
  year: 2008
  end-page: 257
  article-title: Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling
  publication-title: Int J Cancer
– volume: 2
  start-page: e98
  issue: 4
  year: 2004
  article-title: Sequence‐specific inhibition of small RNA function
  publication-title: PLoS Biol
– volume: 7
  start-page: 38
  issue: 1
  year: 2017
  end-page: 51
  article-title: Regulation of multidrug resistance by microRNAs in anti‐cancer therapy
  publication-title: Acta Pharm Sin B
– volume: 35
  start-page: 554
  issue: 3
  year: 2014
  end-page: 563
  article-title: miR‐9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma
  publication-title: Carcinogenesis
– volume: 2014
  start-page: 374598
  year: 2014
  article-title: miR‐375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma
  publication-title: Biomed Res Int
– volume: 42
  start-page: 1699
  year: 2020
  end-page: 1712
  article-title: MicroRNA‐based risk scoring system to identify early‐stage oral squamous cell carcinoma patients at high‐risk for cancer‐specific mortality
  publication-title: Head Neck
– volume: 111
  start-page: 356
  issue: 2
  year: 2020
  end-page: 368
  article-title: miR‐30e‐5p represses angiogenesis and metastasis by directly targeting AEG‐1 in squamous cell carcinoma of the head and neck
  publication-title: Cancer Sci
– volume: 61
  start-page: 109
  issue: 2
  year: 2016
  end-page: 118
  article-title: Tumor‐suppressive microRNAs (miR‐26a/b, miR‐29a/b/c and miR‐218) concertedly suppressed metastasis‐promoting LOXL2 in head and neck squamous cell carcinoma
  publication-title: J Hum Genet
– volume: 23
  start-page: 1229
  issue: 4
  year: 2010
  end-page: 1234
  article-title: MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression
  publication-title: Int J Immunopathol Pharmacol
– volume: 337
  start-page: 115
  issue: 1
  year: 2013
  end-page: 124
  article-title: miR‐211 promotes the progression of head and neck carcinomas by targeting TGFβRII
  publication-title: Cancer Lett
– volume: 8
  start-page: 7040
  year: 2018
  article-title: Cigarette smoke and chewing tobacco alter expression of diferent sets of miRNAs in oral keratinocytes
  publication-title: Sci Rep
– volume: 27
  start-page: 1404
  issue: 4
  year: 2013
  end-page: 1412
  article-title: A functional variant at the miR‐885‐5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer
  publication-title: FASEB J
– volume: 175
  start-page: 47
  year: 2017
  end-page: 51
  article-title: miR‐519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP
  publication-title: Life Sci
– volume: 7
  start-page: 57254
  issue: 35
  year: 2016
  end-page: 57267
  article-title: miR‐31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
  publication-title: Oncotarget
– volume: 8
  start-page: 132
  year: 2017
  end-page: 143
  article-title: Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine
  publication-title: Mol Ther Nucleic Acids
– volume: 37
  start-page: 4169
  issue: 3
  year: 2016
  end-page: 4174
  article-title: MicroRNA‐101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population
  publication-title: Tumour Biol
– volume: 70
  start-page: 1635
  issue: 4
  year: 2010
  end-page: 1644
  article-title: miR‐31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma
  publication-title: Cancer Res
– volume: 20
  start-page: :4799
  issue: 19
  year: 2019
  end-page: 4816
  article-title: Extracellular miRNAs as biomarkers of head and neck cancer progression and metastasis
  publication-title: Int J Mol Sci
– volume: 8
  start-page: 772
  issue: 8
  year: 2019
– volume: 6
  start-page: 604
  issue: 5
  year: 2014
  end-page: 613
  article-title: miR‐21 and miR‐375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival
  publication-title: Am J Transl Res
– volume: 438
  start-page: 685
  year: 2005
  end-page: 689
  article-title: Silencing of microRNAs in vivo with ‘antagomirs’
  publication-title: Nature
– volume: 15
  start-page: 861
  year: 2015
  article-title: MicroRNA‐363 targets myosin 1B to reduce cellular migration in head and neck cancer
  publication-title: BMC Cancer
– volume: 20
  start-page: S406
  year: 2013
  end-page: S414
  article-title: miR‐196a overexpression and miR‐196a2 gene polymorphism are prognostic predictors of oral carcinomas
  publication-title: Ann Surg Oncol
– volume: 10
  issue: 4
  year: 2015
  article-title: MiR‐506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma
  publication-title: PLoS One
– volume: 70
  start-page: 7027
  issue: 18
  year: 2010
  end-page: 7030
  article-title: The promise of microRNA replacement therapy
  publication-title: Cancer Res.
– volume: 8
  start-page: 34630
  issue: 21
  year: 2017
  end-page: 34642
  article-title: A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma
  publication-title: Oncotarget
– volume: 16
  start-page: 7619
  issue: 17
  year: 2015
  end-page: 7625
  article-title: Down regulation of miR‐34a and miR‐143 may indirectly inhibit p53 in Oral squamous cell carcinoma: a pilot study
  publication-title: Asian Pac J Cancer Prev
– volume: 7
  start-page: e2156
  year: 2016
  article-title: miR‐141 is involved in BRD7‐mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma
  publication-title: Cell Death Dis
– volume: 81
  start-page: 128
  year: 2015
  end-page: 141
  article-title: In vivo delivery of miRNAs for cancer therapy: challenges and strategies
  publication-title: Adv Drug Deliv Rev
– volume: 17
  start-page: 173
  issue: 1
  year: 2019
  article-title: The let‐7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD‐L1 degradation
  publication-title: Cell Commun Signal
– ident: e_1_2_4_11_1
  doi: 10.1016/j.cell.2009.01.002
– ident: e_1_2_4_155_1
  doi: 10.1158/0008-5472.CAN-15-1664
– ident: e_1_2_4_3_1
  doi: 10.1007/s10555-017-9690-0
– ident: e_1_2_4_5_1
  doi: 10.1002/jso.23724
– ident: e_1_2_4_118_1
  doi: 10.1166/jbn.2016.2172
– ident: e_1_2_4_170_1
  doi: 10.1080/15384101.2018.1526601
– ident: e_1_2_4_131_1
  doi: 10.3892/ol.2015.3238
– ident: e_1_2_4_86_1
  doi: 10.1016/j.oooo.2017.05.515
– ident: e_1_2_4_57_1
  doi: 10.1089/dna.2016.3464
– ident: e_1_2_4_223_1
  doi: 10.1186/s13046-019-1283-z
– ident: e_1_2_4_171_1
  doi: 10.1002/jcp.26833
– ident: e_1_2_4_104_1
  doi: 10.1038/mt.2014.5
– ident: e_1_2_4_96_1
  doi: 10.18632/oncotarget.8512
– ident: e_1_2_4_197_1
  doi: 10.1139/bcb-2018-0351
– ident: e_1_2_4_53_1
  doi: 10.7314/APJCP.2015.16.17.7619
– ident: e_1_2_4_120_1
  doi: 10.1371/journal.pone.0046367
– ident: e_1_2_4_117_1
  doi: 10.1038/gt.2011.79
– ident: e_1_2_4_56_1
  doi: 10.1038/s41598-018-25498-2
– ident: e_1_2_4_13_1
  doi: 10.1038/nrm3313
– ident: e_1_2_4_94_1
  doi: 10.1158/0008-5472.CAN-13-0395
– ident: e_1_2_4_33_1
  doi: 10.1111/coa.12785
– ident: e_1_2_4_105_1
  doi: 10.1371/journal.pbio.0020098
– ident: e_1_2_4_41_1
  doi: 10.1074/jbc.M115.700021
– ident: e_1_2_4_226_1
  doi: 10.3892/or.2016.4713
– volume: 19
  start-page: 2697
  issue: 14
  year: 2015
  ident: e_1_2_4_216_1
  article-title: miR‐206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Yu WF
– ident: e_1_2_4_18_1
  doi: 10.3390/ijms20194799
– ident: e_1_2_4_63_1
  doi: 10.1096/fj.12-223420
– ident: e_1_2_4_210_1
  doi: 10.3892/ijmm.2014.1625
– ident: e_1_2_4_7_1
  doi: 10.1001/jamaoncol.2016.4510
– ident: e_1_2_4_93_1
  doi: 10.5114/pjp.2016.63781
– ident: e_1_2_4_181_1
  doi: 10.1371/journal.pone.0037601
– ident: e_1_2_4_42_1
  doi: 10.1186/s13046-019-1119-x
– ident: e_1_2_4_163_1
  doi: 10.1016/j.ebiom.2019.11.016
– ident: e_1_2_4_85_1
  doi: 10.1042/BSR20180273
– volume: 20
  start-page: 4340
  issue: 5
  year: 2019
  ident: e_1_2_4_51_1
  article-title: A novel seven‐miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients
  publication-title: Mol Med Rep
  contributor:
    fullname: Lu L
– ident: e_1_2_4_17_1
  doi: 10.3389/fonc.2019.01305
– ident: e_1_2_4_145_1
  doi: 10.1371/journal.pone.0056395
– ident: e_1_2_4_221_1
  doi: 10.1186/s12885-015-1888-3
– ident: e_1_2_4_36_1
  doi: 10.1158/0008-5472.CAN-10-2754
– ident: e_1_2_4_44_1
  doi: 10.1016/j.bbrc.2016.02.105
– ident: e_1_2_4_138_1
  doi: 10.1002/hed.23011
– ident: e_1_2_4_182_1
  doi: 10.3390/cells8121535
– ident: e_1_2_4_177_1
  doi: 10.1016/j.biopha.2016.11.055
– ident: e_1_2_4_190_1
  doi: 10.12659/MSM.895306
– ident: e_1_2_4_14_1
  doi: 10.1016/j.molcel.2011.07.024
– ident: e_1_2_4_196_1
  doi: 10.1111/jop.12300
– ident: e_1_2_4_6_1
  doi: 10.1155/2012/154303
– ident: e_1_2_4_74_1
  doi: 10.1093/carcin/bgq177
– ident: e_1_2_4_28_1
  doi: 10.1007/s13277-014-1790-7
– ident: e_1_2_4_77_1
  doi: 10.1016/j.canep.2014.07.008
– ident: e_1_2_4_83_1
  doi: 10.1073/pnas.0802682105
– ident: e_1_2_4_110_1
  doi: 10.1007/s10616-012-9430-9
– ident: e_1_2_4_144_1
  doi: 10.1038/cddis.2016.64
– ident: e_1_2_4_89_1
  doi: 10.7314/APJCP.2015.16.17.7589
– ident: e_1_2_4_102_1
  doi: 10.4161/cc.7.6.5834
– ident: e_1_2_4_141_1
  doi: 10.1002/ijc.31638
– ident: e_1_2_4_46_1
  doi: 10.1002/hed.21540
– ident: e_1_2_4_203_1
  doi: 10.1007/s00432-015-2087-y
– ident: e_1_2_4_75_1
  doi: 10.1093/carcin/bgp099
– volume: 6
  start-page: 604
  issue: 5
  year: 2014
  ident: e_1_2_4_127_1
  article-title: miR‐21 and miR‐375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival
  publication-title: Am J Transl Res
  contributor:
    fullname: Hu A
– volume: 5
  start-page: :e336.
  issue: 6
  year: 2016
  ident: e_1_2_4_108_1
  article-title: Pharmacokinetics and pharmacodynamics of a 13‐mer LNA‐inhibitor‐miR‐221 in mice and non‐human primates
  publication-title: Mol Ther Nucleic Acids
  contributor:
    fullname: Gallo MEC
– ident: e_1_2_4_115_1
  doi: 10.1016/S1470-2045(17)30621-6
– ident: e_1_2_4_180_1
  doi: 10.3892/ijmm_00000378
– ident: e_1_2_4_8_1
  doi: 10.1007/s00405-015-3893-1
– ident: e_1_2_4_81_1
  doi: 10.1371/journal.pone.0079584
– ident: e_1_2_4_26_1
  doi: 10.1093/carcin/bgt354
– ident: e_1_2_4_150_1
  doi: 10.1186/1476-4598-13-218
– ident: e_1_2_4_82_1
  doi: 10.18632/oncotarget.13599
– volume: 18
  start-page: 2444
  issue: 17
  year: 2014
  ident: e_1_2_4_67_1
  article-title: Two polymorphisms of CD44 3'UTR weaken the binding of miRNAs and associate with naso‐pharyngeal carcinoma in a Chinese population
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Lou F
– ident: e_1_2_4_64_1
  doi: 10.1007/s13277-015-4682-6
– ident: e_1_2_4_20_1
  doi: 10.1158/1078-0432.CCR-13-2675
– ident: e_1_2_4_2_1
  doi: 10.3322/caac.21492
– ident: e_1_2_4_4_1
  doi: 10.1186/1758-3284-2-15
– ident: e_1_2_4_90_1
  doi: 10.1111/odi.12241
– ident: e_1_2_4_92_1
  doi: 10.1155/2015/298378
– ident: e_1_2_4_140_1
  doi: 10.1016/j.oraloncology.2013.01.001
– ident: e_1_2_4_214_1
  doi: 10.2353/ajpath.2009.080731
– ident: e_1_2_4_217_1
  doi: 10.1371/journal.pone.0102403
– ident: e_1_2_4_29_1
  doi: 10.1016/j.jbiosc.2015.02.002
– ident: e_1_2_4_31_1
  doi: 10.21873/anticanres.12618
– ident: e_1_2_4_162_1
  doi: 10.1007/s00432-013-1469-2
– ident: e_1_2_4_98_1
  doi: 10.1016/j.omtn.2017.06.005
– ident: e_1_2_4_199_1
  doi: 10.1016/j.oooo.2015.02.486
– ident: e_1_2_4_16_1
  doi: 10.1038/bjc.2011.29
– ident: e_1_2_4_233_1
  doi: 10.1002/jcp.29458
– ident: e_1_2_4_202_1
  doi: 10.1177/039463201002300427
– ident: e_1_2_4_113_1
  doi: 10.1016/j.addr.2014.05.009
– ident: e_1_2_4_132_1
  doi: 10.1016/j.oraloncology.2009.12.005
– ident: e_1_2_4_49_1
  doi: 10.1002/hed.26089
– ident: e_1_2_4_213_1
  doi: 10.7150/thno.38507
– ident: e_1_2_4_227_1
  doi: 10.1371/journal.pone.0122851
– ident: e_1_2_4_52_1
  doi: 10.1016/j.neo.2019.06.004
– ident: e_1_2_4_175_1
  doi: 10.1158/0008-5472.CAN-10-1850
– ident: e_1_2_4_99_1
  doi: 10.1158/0008-5472.CAN-10-2010
– ident: e_1_2_4_109_1
  doi: 10.1016/j.addr.2007.03.005
– ident: e_1_2_4_187_1
  doi: 10.1097/CAD.0000000000000865
– ident: e_1_2_4_61_1
  doi: 10.1002/ijc.30849
– ident: e_1_2_4_185_1
  doi: 10.1002/hed.25866
– ident: e_1_2_4_224_1
  doi: 10.1038/sj.bjc.6605811
– ident: e_1_2_4_206_1
  doi: 10.3892/mmr.2016.6059
– ident: e_1_2_4_59_1
  doi: 10.1093/nar/gkm480
– ident: e_1_2_4_80_1
  doi: 10.1371/journal.pone.0047544
– ident: e_1_2_4_101_1
  doi: 10.1038/nm.1880
– ident: e_1_2_4_128_1
  doi: 10.2174/1389201015666140519110616
– volume: 38
  start-page: 209
  issue: 1
  year: 2011
  ident: e_1_2_4_191_1
  article-title: Caveolin‐1 mediates tumor cell migration and invasion and its regulation by miR‐133a in head and neck squamous cell carcinoma
  publication-title: Int J Oncol
  contributor:
    fullname: Nohata N
– ident: e_1_2_4_167_1
  doi: 10.18632/oncotarget.213
– ident: e_1_2_4_125_1
  doi: 10.1002/ijc.23831
– ident: e_1_2_4_147_1
  doi: 10.1016/j.oooo.2013.10.017
– ident: e_1_2_4_204_1
  doi: 10.1007/s13277-014-2406-y
– ident: e_1_2_4_114_1
  doi: 10.1056/NEJMoa1209026
– ident: e_1_2_4_165_1
  doi: 10.2147/OTT.S224325
– ident: e_1_2_4_9_1
  doi: 10.1016/j.gendis.2014.07.002
– ident: e_1_2_4_66_1
  doi: 10.1093/mutage/get035
– ident: e_1_2_4_126_1
  doi: 10.1093/hmg/ddp446
– volume: 7
  start-page: 6784
  issue: 10
  year: 2014
  ident: e_1_2_4_47_1
  article-title: MiR‐634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Peng X
– ident: e_1_2_4_97_1
  doi: 10.1158/1055-9965.EPI-18-0002
– ident: e_1_2_4_123_1
  doi: 10.1093/carcin/bgp277
– ident: e_1_2_4_156_1
  doi: 10.1007/s13277-013-0718-y
– ident: e_1_2_4_45_1
  doi: 10.3389/fonc.2020.00060
– volume: 31
  start-page: 3859
  issue: 11
  year: 2011
  ident: e_1_2_4_215_1
  article-title: Down‐regulation of MiR‐206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression
  publication-title: Anticancer Res
  contributor:
    fullname: Zhang T
– ident: e_1_2_4_27_1
  doi: 10.1038/onc.2013.448
– ident: e_1_2_4_12_1
  doi: 10.1016/S0092-8674(04)00045-5
– ident: e_1_2_4_133_1
  doi: 10.1016/j.febslet.2010.08.040
– ident: e_1_2_4_24_1
  doi: 10.1016/j.canlet.2015.04.006
– ident: e_1_2_4_87_1
  doi: 10.1007/s13277-015-4249-6
– ident: e_1_2_4_189_1
  doi: 10.1038/bjc.2012.330
– ident: e_1_2_4_50_1
  doi: 10.3390/cells8080772
– ident: e_1_2_4_172_1
  doi: 10.3892/or.2011.1571
– ident: e_1_2_4_152_1
  doi: 10.3390/cancers11091347
– ident: e_1_2_4_220_1
  doi: 10.1016/j.biocel.2012.12.004
– ident: e_1_2_4_154_1
  doi: 10.1016/j.canlet.2013.05.032
– ident: e_1_2_4_129_1
  doi: 10.1016/j.rpor.2017.10.003
– volume: 15
  start-page: 649
  issue: 1
  year: 2018
  ident: e_1_2_4_212_1
  article-title: Dysregulation of miR‐200 family microRNAs and epithelial‐mesenchymal transition markers in oral squamous cell carcinoma
  publication-title: Oncol Lett
  contributor:
    fullname: Arunkumar G
– ident: e_1_2_4_25_1
  doi: 10.3892/ijo.2014.2704
– ident: e_1_2_4_62_1
  doi: 10.1093/carcin/bgr209
– ident: e_1_2_4_229_1
  doi: 10.1042/BSR20181882
– ident: e_1_2_4_55_1
  doi: 10.1016/j.oraloncology.2017.07.009
– ident: e_1_2_4_148_1
  doi: 10.1158/1078-0432.CCR-07-0666
– ident: e_1_2_4_111_1
  doi: 10.4103/2230-973X.167646
– ident: e_1_2_4_69_1
  doi: 10.1620/tjem.233.33
– ident: e_1_2_4_153_1
  doi: 10.1002/cncr.25009
– ident: e_1_2_4_184_1
  doi: 10.1111/odi.12133
– ident: e_1_2_4_39_1
  doi: 10.1016/j.apsb.2016.09.002
– ident: e_1_2_4_136_1
  doi: 10.1158/0008-5472.CAN-09-2291
– ident: e_1_2_4_211_1
  doi: 10.1111/his.12668
– ident: e_1_2_4_22_1
  doi: 10.1002/jcb.22995
– ident: e_1_2_4_208_1
  doi: 10.1371/journal.pone.0056634
– ident: e_1_2_4_174_1
  doi: 10.1186/s13046-015-0242-6
– ident: e_1_2_4_200_1
  doi: 10.1016/j.biocel.2015.02.006
– ident: e_1_2_4_58_1
  doi: 10.1371/journal.pone.0205077
– ident: e_1_2_4_168_1
  doi: 10.1016/j.bbrc.2012.12.097
– ident: e_1_2_4_21_1
  doi: 10.1158/1078-0432.CCR-08-3053
– ident: e_1_2_4_73_1
  doi: 10.1093/carcin/bgx019
– ident: e_1_2_4_198_1
  doi: 10.18632/aging.101791
– ident: e_1_2_4_176_1
  doi: 10.18632/oncotarget.23194
– ident: e_1_2_4_142_1
  doi: 10.1007/s12032-013-0789-z
– ident: e_1_2_4_116_1
  doi: 10.1186/s40169-018-0211-8
– ident: e_1_2_4_23_1
  doi: 10.1186/1476-4598-13-51
– ident: e_1_2_4_159_1
  doi: 10.1111/j.1600-0714.2010.01005.x
– ident: e_1_2_4_186_1
  doi: 10.4149/neo_2018_180811N611
– volume: 8
  start-page: 4588
  issue: 5
  year: 2015
  ident: e_1_2_4_143_1
  article-title: MiRNA‐139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Ren Y
– ident: e_1_2_4_15_1
  doi: 10.1017/S0022215113000753
– ident: e_1_2_4_201_1
  doi: 10.3892/etm.2016.3847
– ident: e_1_2_4_137_1
  doi: 10.18632/oncotarget.11138
– ident: e_1_2_4_54_1
  doi: 10.1186/s12943-015-0452-8
– ident: e_1_2_4_76_1
  doi: 10.1002/gcc.22099
– ident: e_1_2_4_146_1
  doi: 10.3892/ijmm.2016.2529
– ident: e_1_2_4_178_1
  doi: 10.1111/cas.14259
– ident: e_1_2_4_48_1
  doi: 10.1080/15384047.2014.1001287
– ident: e_1_2_4_130_1
  doi: 10.1186/s13000-015-0256-6
– ident: e_1_2_4_205_1
  doi: 10.12659/MSM.898110
– ident: e_1_2_4_194_1
  doi: 10.1016/j.canlet.2009.05.030
– ident: e_1_2_4_236_1
  doi: 10.1371/journal.pone.0101695
– volume: 6
  start-page: 675
  issue: 3
  year: 2012
  ident: e_1_2_4_183_1
  article-title: Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells
  publication-title: Mol Med Rep
  contributor:
    fullname: Yan B
– ident: e_1_2_4_232_1
  doi: 10.1038/s41419-019-2154-4
– ident: e_1_2_4_139_1
  doi: 10.1007/s13277-015-3038-6
– ident: e_1_2_4_231_1
  doi: 10.1111/cas.12499
– ident: e_1_2_4_160_1
  doi: 10.3892/or.2014.2985
– ident: e_1_2_4_65_1
  doi: 10.1016/j.bbrc.2013.02.024
– ident: e_1_2_4_106_1
  doi: 10.1038/nature04303
– ident: e_1_2_4_107_1
  doi: 10.1038/ncb2024
– ident: e_1_2_4_122_1
  doi: 10.1186/s12935-020-1096-3
– ident: e_1_2_4_35_1
  doi: 10.1038/jhg.2015.120
– ident: e_1_2_4_173_1
  doi: 10.1186/s12935-015-0217-x
– ident: e_1_2_4_164_1
  doi: 10.1016/j.molonc.2016.03.001
– ident: e_1_2_4_84_1
  doi: 10.1002/cncr.25323
– ident: e_1_2_4_91_1
  doi: 10.1007/s13353-018-0445-6
– ident: e_1_2_4_72_1
  doi: 10.1016/j.ejca.2015.04.016
– ident: e_1_2_4_19_1
  doi: 10.1074/jbc.M112.366518
– ident: e_1_2_4_68_1
  doi: 10.1093/carcin/bgx056
– volume: 37
  start-page: 5425
  issue: 10
  year: 2017
  ident: e_1_2_4_30_1
  article-title: Suppression of oral carcinoma oncogenic activity by microRNA‐203
  publication-title: Anticancer Res
  contributor:
    fullname: Lim HS
– ident: e_1_2_4_119_1
  doi: 10.1016/j.biopha.2016.09.047
– ident: e_1_2_4_70_1
  doi: 10.18632/oncotarget.16120
– ident: e_1_2_4_79_1
  doi: 10.5732/cjc.30.0381
– ident: e_1_2_4_193_1
  doi: 10.1111/cpr.12287
– ident: e_1_2_4_10_1
  doi: 10.18632/oncotarget.19224
– ident: e_1_2_4_88_1
  doi: 10.1371/journal.pone.0176044
– volume: 5
  start-page: 1775
  issue: 5
  year: 2015
  ident: e_1_2_4_37_1
  article-title: MiR‐21/miR‐375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma
  publication-title: Am J Cancer Res
  contributor:
    fullname: Hu A
– ident: e_1_2_4_134_1
  doi: 10.3892/or.2016.4891
– ident: e_1_2_4_195_1
  doi: 10.1002/ijc.25320
– ident: e_1_2_4_78_1
  doi: 10.18632/oncotarget.8908
– ident: e_1_2_4_161_1
  doi: 10.1186/s12920-015-0102-4
– volume: 6
  start-page: 131
  issue: 3
  year: 2009
  ident: e_1_2_4_218_1
  article-title: MicroRNA‐222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines
  publication-title: Cancer Genomics Proteomics
  contributor:
    fullname: Liu X
– ident: e_1_2_4_192_1
  doi: 10.1002/ijc.23583
– ident: e_1_2_4_103_1
  doi: 10.1038/onc.2009.445
– ident: e_1_2_4_209_1
  doi: 10.3892/mmr.2017.7460
– ident: e_1_2_4_157_1
  doi: 10.1371/journal.pone.0086149
– ident: e_1_2_4_219_1
  doi: 10.1186/s12935-016-0372-8
– ident: e_1_2_4_40_1
  doi: 10.1016/j.oraloncology.2015.08.002
– ident: e_1_2_4_151_1
  doi: 10.1016/j.bbrc.2018.05.052
– ident: e_1_2_4_112_1
  doi: 10.1371/journal.pone.0004029
– ident: e_1_2_4_100_1
  doi: 10.1016/j.ebiom.2016.09.017
– ident: e_1_2_4_149_1
  doi: 10.1245/s10434-012-2618-6
– ident: e_1_2_4_230_1
  doi: 10.1080/21691401.2019.1647222
– ident: e_1_2_4_34_1
  doi: 10.18632/oncotarget.709
– ident: e_1_2_4_222_1
  doi: 10.1186/1476-4598-12-123
– volume: 54
  start-page: 1245
  issue: 4
  year: 2019
  ident: e_1_2_4_207_1
  article-title: Upregulation of microRNA‐194‐5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway
  publication-title: Int J Oncol
  contributor:
    fullname: Xu S
– ident: e_1_2_4_60_1
  doi: 10.1016/j.ajhg.2011.03.008
– ident: e_1_2_4_121_1
  doi: 10.1002/cam4.863
– volume: 7
  start-page: 56
  issue: 1
  year: 2014
  ident: e_1_2_4_124_1
  article-title: MiR‐19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP‐2 expression
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Wu TY
– ident: e_1_2_4_169_1
  doi: 10.12659/MSM.895683
– ident: e_1_2_4_158_1
  doi: 10.3892/mmr.2015.4168
– ident: e_1_2_4_225_1
  doi: 10.1158/0008-5472.CAN-13-1297
– ident: e_1_2_4_71_1
  doi: 10.1038/srep07434
– ident: e_1_2_4_135_1
  doi: 10.1016/j.joms.2017.03.025
– ident: e_1_2_4_234_1
  doi: 10.1186/s12964-019-0490-8
– ident: e_1_2_4_179_1
  doi: 10.1158/1078-0432.CCR-18-0716
– ident: e_1_2_4_188_1
  doi: 10.1016/j.redox.2019.101140
– ident: e_1_2_4_38_1
  doi: 10.1155/2014/374598
– ident: e_1_2_4_228_1
  doi: 10.1016/j.lfs.2017.03.010
– ident: e_1_2_4_235_1
  doi: 10.1002/gcc.20765
– ident: e_1_2_4_32_1
  doi: 10.18632/oncotarget.6972
– ident: e_1_2_4_166_1
  doi: 10.1002/cam4.2915
– ident: e_1_2_4_95_1
  doi: 10.18632/oncotarget.9014
– ident: e_1_2_4_43_1
  doi: 10.18632/oncotarget.6253
SSID ssj0003642
Score 2.4325988
SecondaryResourceType review_article
Snippet Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic and...
Abstract Head and neck (HN) squamous cell carcinoma (SCC) is the eighth most common human cancer worldwide. Besides tobacco and alcohol consumption, genetic...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 645
SubjectTerms Apoptosis
Cell cycle
Cell differentiation
Epigenetics
Gene expression
Head & neck cancer
head and neck cancer
MicroRNAs
miRNA
SNVs
Squamous cell carcinoma
therapy
Tobacco
Tumor cells
Title microRNAs deregulation in head and neck squamous cell carcinoma
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.26533
https://www.ncbi.nlm.nih.gov/pubmed/33159410
https://www.proquest.com/docview/2476499039
https://search.proquest.com/docview/2458724834
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED5BJxYe4hUoyCAGllDXduxEDKiirTpVCDqwRY7tAEJNgdD_j-08UIWQkNgixZFztu_83fn8HcCFIpHGiogQG8atg8JZmGGhQ8eOpbTJRexv8U8exPQxHo4cTc51cxem4odoA25OM7y9dgous7L3TRr6bPQV4RatWPtrvQR_fYPetVaYcladdDLq4iusYRXCpNd-uboX_QCYq3jVbzjjrX_96jZs1jgTDaqFsQNrptiFm7lLv7ufDkrkanQ-1aW70EuBrE3WSBYaFUa9ovJ9KV1MALm4PlKu3lCxmMs9mI1Hs9tJWFdQCBWzyCwUpp9rInkSJTjjnGGZW4_IJDkxEc7zvuFCOhein5EsMzLKKRHWpYqNks4S0H3oFIvCHAJKdKKkdmR3WcIsxJOcWtU3yhDNKY9UAOfNUKZvFU9GWjEik9SKn3rxA-g2g5zWqlKmhAlu3S5MkwDO2td2kTsJZWGssLZNFAvi4p4BHFST0_ZCqUVkrI8DuPRz8Hv36WQ09A9Hf296DBvEZbH4PO0udD4_luYE1ku9PPXr7QtH89O4
link.rule.ids 315,782,786,1408,27935,27936,46066,46490
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50PejFB76qq0bx4KWaTdJkA4KIrqyoi-gevJU0SVXE-lj3_5tpdysiguCt0JR0kszkm8nkG4BdyxJHLVMx9UIGB0WKOKPKxciOZZ3PVbu8xd-9Vb279mkHaXIOx3dhKn6IOuCGmlHaa1RwDEgffLGGPni3z2SAK5MwJaTQWLiB8-vaDnMpqrNOwTHCIsa8QpQd1J9-341-QMzviLXccs7m_vez8zA7gprkuFobCzDhi0U4esYMvJve8YBgmc77UfUu8liQYJYdMYUjhbdPZPA2NBgWIBjaJxZLDhUvz2YJ-med_kk3HhVRiK0I4CxWvpU7ZqRONM2kFNTkwSnyOmc-oXne8lIZ9CJaGcsyb5KcMxW8qra3Bo0BX4ZG8VL4VSDaaWsc8t1lWgSUZyQP2u-tZ05ymdgIdsZjmb5WVBlpRYrM0iB-WoofQXM8yulIWwYpEyrMn6ZcR7Bdvw7rHCU0hQ_ChjZJWzEMfUawUs1O3QvnAZSJFo1gr5yE37tPu53T8mHt7023YLrbv7pML897F-swwzCppUzbbkLj433oN2By4Iab5eL7BK6719k
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_cBPHFD_yqTo3igy91WZImKz6IuI2JMob64FtJk1RFrNO5_99cu1VEBMG3QlPSS3KX310uvwM4Miyy1DAVUiekd1CkCFOqbIjsWMa6TLWLW_z9WzW4b3e6SJNzOrsLU_JDVAE31IzCXqOCj2zW_CINfXT2hEmPVmowLxCG4_0NPqzMMJeiPOoUHAMsYkYrRFmz-vT7ZvQDYX4HrMWO01v-17-uwNIUaJLzcmWswpzL1-DsBfPvbgbnY4JFOh-mtbvIU068UbZE55bkzjyT8dtEY1CAYGCfGCw4lL--6HW463XvLvrhtIRCaISHZqFyrcwyLeMopqmUgurMu0QuzpiLaJa1nFQafYhWytLU6SjjTHmfqu2MRlPAN6Cev-ZuC0hsY6Mtst2lsfAYT0vudd8Zx6zkMjIBHM6GMhmVRBlJSYnMEi9-UogfQGM2yMlUV8YJE0p6v4vyOICD6rVf5Sihzp0X1reJ2oph4DOAzXJyql4495BMtGgAx8Uc_N590u92ioftvzfdh4Vhp5dcXw6udmCRYUZLkbPdgPrH-8TtQm1sJ3vF0vsEQDbWiA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=microRNAs+deregulation+in+head+and+neck+squamous+cell+carcinoma&rft.jtitle=Head+%26+neck&rft.au=Carron%2C+Juliana&rft.au=Torricelli%2C+Caroline&rft.au=Silva%2C+Janet+K.&rft.au=Queiroz%2C+Gabriela+S.+R.&rft.date=2021-02-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1043-3074&rft.eissn=1097-0347&rft.volume=43&rft.issue=2&rft.spage=645&rft.epage=667&rft_id=info:doi/10.1002%2Fhed.26533&rft.externalDBID=10.1002%252Fhed.26533&rft.externalDocID=HED26533
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon